Gulf & Middle East · Regional markets · Argaam

Jamjoom Pharma profit rises 5% to SAR 416.05 M in 9M 2026; Q3 at SAR 110.2M

Published by Argaam · Saudi Arabia 14 h ago

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) reported a net profit of SAR 416.05 million for the first nine months of 2026, an increase of 5.13% from SAR 395.7 million in…

Read the full article on Argaam Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.argaam.com)

Also worth reading

AGBI

Qatar highlights global police cooperation as key to tackling cross-border crime

Arab News Business

‘Love for the poor’: Lula’s enduring appeal in Brazil’s Northeast

Globes

Jamjoom Pharma profit rises 5% to SAR 416.05 M in 9M 2026; Q3 at SAR 110.2M

Share

Also worth reading

Saudi Arabia seeks developers for new Jeddah logistics zone

UAE–Singapore trade jumps 25% to $6.5bn as countries launch CEPA talks

Exxon signs major oilfield water agreement in Iraq

Qatar highlights global police cooperation as key to tackling cross-border crime

‘Love for the poor’: Lula’s enduring appeal in Brazil’s Northeast

Police fraud unit questions Likud minister May Golan